Yang K - Search Results

1

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Among authors: yang k. Nat Commun. 2019 Aug 28;10(1):3874. doi: 10.1038/s41467-019-11782-w. Nat Commun. 2019. PMID: 31462678 Free PMC article.

2

Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.

Liang Y, Yang K, Guo J, Wroblewska J, Fu YX, Peng H. Liang Y, et al. Among authors: yang k. Sci Rep. 2015 May 20;5:10406. doi: 10.1038/srep10406. Sci Rep. 2015. PMID: 25993659 Free PMC article.

3

Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse.

Pu Y, Xu M, Liang Y, Yang K, Guo Y, Yang X, Fu YX. Pu Y, et al. Among authors: yang k, yang x. Sci Transl Med. 2016 Apr 6;8(333):333ra47. doi: 10.1126/scitranslmed.aad5659. Sci Transl Med. 2016. PMID: 27053771

4

Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression.

Liao J, Luan Y, Ren Z, Liu X, Xue D, Xu H, Sun Z, Yang K, Peng H, Fu YX. Liao J, et al. Among authors: yang k. Cancer Immunol Res. 2017 Jul;5(7):560-570. doi: 10.1158/2326-6066.CIR-16-0221. Epub 2017 May 22. Cancer Immunol Res. 2017. PMID: 28533311 Free PMC article.

5

T Cell-Derived Lymphotoxin Is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response.

Yang K, Liang Y, Sun Z, Xue D, Xu H, Zhu M, Fu YX, Peng H. Yang K, et al. J Virol. 2018 Jun 29;92(14):e00428-18. doi: 10.1128/JVI.00428-18. Print 2018 Jul 15. J Virol. 2018. PMID: 29743364 Free PMC article.

6

Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion.

Liu X, Liu L, Ren Z, Yang K, Xu H, Luan Y, Fu K, Guo J, Peng H, Zhu M, Fu YX. Liu X, et al. Among authors: yang k. Cell Rep. 2018 Aug 21;24(8):2101-2111. doi: 10.1016/j.celrep.2018.07.062. Cell Rep. 2018. PMID: 30134171 Free article.

7

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection.

Yang K, Liang Y, Sun Z, Liu L, Liao J, Xu H, Zhu M, Fu YX, Peng H. Yang K, et al. Sci Rep. 2018 Dec 7;8(1):17727. doi: 10.1038/s41598-018-36012-z. Sci Rep. 2018. PMID: 30531962 Free PMC article.

8

Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling.

Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, Lin W, Chang EB, Weichselbaum RR, Fu YX. Shi Y, et al. Among authors: yang k. J Exp Med. 2020 May 4;217(5):e20192282. doi: 10.1084/jem.20192282. J Exp Med. 2020. PMID: 32142585 Free PMC article.

9

Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8⁺ T-cell response and effective tumor control.

Sun Z, Ren Z, Yang K, Liu Z, Cao S, Deng S, Xu L, Liang Y, Guo J, Bian Y, Xu H, Shi J, Wang F, Fu YX, Peng H. Sun Z, et al. Among authors: yang k. Nat Commun. 2020 Apr 1;11(1):1716. doi: 10.1038/s41467-020-15532-1. Nat Commun. 2020. PMID: 32238807 Free PMC article.

10

RIG-I-Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy.

Zheng W, Ranoa DRE, Huang X, Hou Y, Yang K, Poli EC, Beckett MA, Fu YX, Weichselbaum RR. Zheng W, et al. Among authors: yang k. Cancer Res. 2020 Dec 15;80(24):5633-5641. doi: 10.1158/0008-5472.CAN-20-2324. Epub 2020 Oct 21. Cancer Res. 2020. PMID: 33087322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,524 results

Search Page

Filters